Dramatic complete response in patient with lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dramatic complete response in patient with lung adenocarcinoma

Published:2009-12 Issue:12 Volume:11 Page:851-853
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Serrano Solares Sara,Isla Casado Dolores,Vidal Losada María Jesús,Tobeña Puyal María,Ferrer Pérez Ana Isabel,Pajares Isabel

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-009-0455-2.pdf

Reference11 articles.

1. Burdett S, Arriagada R, Auperin A et al (2008) Chemotherapy in addition to supportive care improves survival in advanced non-small cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol 26:4617–4625

2. Pfister D, Johnson D, Azzoli C et al (2004) American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol 22:330–353

3. Soon Y, Stockler MR, Boyer M et al (2008) Duration of chemotherapy for advanced non-small cell lung cancer: an updated systematic review and meta-analysis. J Clin Oncol 26:427s

4. Scagliotti G, Purvish P, von Pawel J et al (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naïve patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26:3543–3551

5. Sandler A, Gray R, Perry MC et al (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355:2542–2550

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases;Cancer Chemotherapy and Pharmacology;2013-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3